For their study, researchers conducted a six-week prospective study to determine the frequency, reasons for and adverse effects associated with unnecessary fluoroquinolone antibiotic therapy.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Of more than 1,770 days of fluoroquinolone antibiotic therapy, 39 percent of those were unnecessary, and the most common reasons for unnecessary administration was administration of antimicrobials for non-infectious or non-bacterial syndromes. Researchers also found the most common syndrome linked with unnecessary fluoroquinolone antibiotic therapy was urinary tract infection or asymptomatic bacteriuria. What’s more, 27 percent of patients experienced an adverse outcome due to the unnecessary therapy, including adverse GI effects.
Read the study about unnecessary fluoroquinolone antibiotic therapy (pdf).
Related Articles on Medication Safety:
Only 6 Adverse Errors Submitted to Oregon Public Reporting System in Past 3 Years
FDA: Safety Labeling Changes Made to Prescribing Information for 47 Products in May
Healthcare Experts Offer “Principles of Conservative Prescribing”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
